Development of key technologies for the early warning of cardiorenal metabolic syndrome based on multimodal imaging, genomics, and metabolomics

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 2d71ccd484656dc362cf2da67a11edd60cb994d8
First added on: Oct 10, 2026